GO:0004590 orotidine-5'-phosphate decarboxylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004590 describes the molecular function of orotidine-5'-phosphate decarboxylase (ODCase), which catalyzes the conversion of orotidine 5'-monophosphate (OMP) to uridine 5'-monophosphate (UMP) and carbon dioxide.
• ODCase is one of the most proficient enzymes known, accelerating a reaction that is virtually impossible without catalysis by a factor of approximately 10^17.
• The enzyme is conserved across all domains of life, from bacteria such as Escherichia coli to yeast, Plasmodium falciparum, and humans [1, 6, 8].
• In humans, ODCase activity is part of the bifunctional UMP synthase enzyme, which also contains orotate phosphoribosyltransferase activity.
• ODCase is a validated target for anticancer and antiparasitic drug development, with inhibitors showing structure-activity relationships in preclinical studies.
• Studying GO:0004590 requires integrating structural biology, enzymology, and CRISPR-based gene editing to dissect its role in pyrimidine metabolism and disease [3, 4].
Description
Orotidine-5'-phosphate decarboxylase activity (GO:0004590) is a molecular function that catalyzes the final step in the de novo biosynthesis of uridine 5'-monophosphate (UMP), a critical precursor for all pyrimidine nucleotides. This reaction, which converts orotidine 5'-phosphate (OMP) to UMP and carbon dioxide, is essential for RNA and DNA synthesis, protein glycosylation, and phospholipid metabolism. The enzyme responsible for this activity, ODCase, is renowned for its extraordinary catalytic proficiency, making it a paradigm for understanding enzyme mechanism and evolution [4, 7]. Researchers study GO:0004590 not only to unravel fundamental principles of catalysis but also to develop therapeutic strategies against cancer and infectious diseases, as ODCase is a validated drug target. The enzyme is conserved from bacteria to humans, and its dysfunction or inhibition can disrupt pyrimidine homeostasis, leading to cell death or growth arrest [6, 8].
orotidine-5'-phosphate decarboxylase activity At A Glance
| GO ID | GO:0004590 |
|---|---|
| GO term | orotidine-5'-phosphate decarboxylase activity |
| Ontology | molecular_function |
| Synonym | ODCase activity, OMP-DC, OMPdcase activity, OMP decarboxylase activity, orotate decarboxylase activity, orotate monophosphate decarboxylase activity, orotic decarboxylase activity, orotidine-5'-monophosphate decarboxylase activity, orotidine-5'-phosphate carboxy-lyase activity, orotidine-5'-phosphate carboxy-lyase (UMP-forming), orotidine 5'-phosphate decarboxylase activity, orotidine monophosphate decarboxylase activity, orotidine phosphate decarboxylase activity, orotidylic acid decarboxylase activity, orotidylic decarboxylase activity, orotodylate decarboxylase activity, UMP synthase activity, uridine 5'-monophosphate synthase activity |
| Major function | Catalyzes the conversion of orotidine 5'-phosphate to UMP and CO2, the final step in de novo pyrimidine biosynthesis. |
| Reaction | H+ + orotidine 5'-phosphate = CO2 + UMP |
| Catalytic proficiency | One of the most proficient enzymes known, with a rate enhancement of approximately 10^17. |
| Metal requirement | Yeast ODCase retains activity in the absence of metals, indicating that metals are not essential for catalysis. |
| Subcellular location | Cytoplasm; in humans, part of the bifunctional UMP synthase. |
| Disease relevance | Target for anticancer and antiparasitic drugs; mutations can cause orotic aciduria [2, 6]. |
What Is GO:0004590?
GO:0004590, orotidine-5'-phosphate decarboxylase activity, is defined as the catalysis of the reaction: H+ + orotidine 5'-phosphate = CO2 + UMP. In other words, it is the enzyme activity that removes a carboxyl group from orotidine 5'-monophosphate (OMP) to produce uridine 5'-monophosphate (UMP) and carbon dioxide. This activity is synonymous with OMP decarboxylase, ODCase, and UMP synthase activity, reflecting its role in pyrimidine biosynthesis.
Why Is orotidine-5'-phosphate decarboxylase activity Important in Cell Biology?
GO:0004590 is fundamentally important because it represents the terminal step in the de novo synthesis of UMP, a nucleotide required for RNA, DNA, and various metabolic processes. The extraordinary catalytic power of ODCase has made it a model system for understanding enzyme mechanism, and its conservation across species highlights its essential role in cellular life. In medicine, ODCase is a target for anticancer agents such as inhibitors that mimic the transition state, and for antiparasitic drugs against pathogens like Plasmodium falciparum [2, 6]. Moreover, genetic defects in the bifunctional UMP synthase can lead to hereditary orotic aciduria, a rare metabolic disorder. Thus, research on GO:0004590 bridges basic enzymology, structural biology, and translational medicine.
• Essential for de novo pyrimidine biosynthesis and UMP production.
• One of the most catalytically proficient enzymes known, serving as a benchmark for enzyme mechanism studies.
• Validated target for anticancer drug discovery, with inhibitors showing structure-activity relationships.
• Critical for the survival of pathogens such as Plasmodium falciparum, making it a potential antiparasitic target.
• Mutations in the bifunctional UMP synthase can cause orotic aciduria and related metabolic disorders.
• Conserved across bacteria, yeast, plants, and humans, enabling comparative studies [1, 8].
• Involved in nucleotide pool homeostasis, affecting DNA repair and replication.
• Used as a selectable marker in yeast genetics (URA3 gene).
• Provides insights into enzyme evolution and catalytic promiscuity.
• Enables CRISPR-based functional genomics studies of pyrimidine metabolism.
Molecular Mechanism of orotidine-5'-phosphate decarboxylase activity
Substrate Binding and Orientation
In simple terms: The enzyme grabs the substrate OMP and positions it perfectly for the reaction.
ODCase binds orotidine 5'-phosphate (OMP) in a specific orientation that places the carboxylate group in a hydrophobic environment, destabilizing the ground state and facilitating decarboxylation. Protein-ribofuranosyl interactions are critical for activating the substrate and stabilizing the transition state, as shown by mutagenesis and kinetic studies. The enzyme uses a combination of hydrogen bonding and electrostatic interactions to orient the substrate, with contributions from conserved residues such as lysine and aspartate.
Catalytic Mechanism and Transition State Stabilization
In simple terms: The enzyme lowers the energy barrier by stabilizing the unstable intermediate formed during the reaction.
The decarboxylation of OMP proceeds through a vinyl anion intermediate that is stabilized by the enzyme, although the exact mechanism remains debated. ODCase achieves a rate enhancement of approximately 10^17 by utilizing a combination of ground-state destabilization and transition-state stabilization, without the need for metal ions or cofactors [1, 7]. Recent studies highlight the role of protein-ribofuranosyl interactions in activating the substrate for catalysis, providing insights into the limits of enzyme efficiency.
Role of Metal Ions and Cofactors
In simple terms: Unlike many enzymes, ODCase does not require metals to work.
Yeast ODCase retains full activity in the absence of metals, demonstrating that metals are not essential for catalysis. This distinguishes ODCase from many other decarboxylases and underscores its unique mechanism. The enzyme also does not require any cofactors, relying solely on its protein scaffold for catalysis.
Enzyme Structure and Active Site Architecture
In simple terms: The enzyme has a specialized pocket that fits the substrate like a lock and key.
ODCase adopts a TIM barrel fold, with the active site located at the C-terminal end of the barrel. The active site contains conserved residues that interact with the substrate, including a lysine that forms a Schiff base-like interaction and an aspartate that hydrogen bonds to the ribose hydroxyls. Structural studies of ODCase from various organisms, including Escherichia coli and yeast, reveal a highly conserved active site architecture.
Bifunctional UMP Synthase in Higher Organisms
In simple terms: In humans and some parasites, the enzyme is fused with another enzyme that makes the substrate.
In humans and Plasmodium falciparum, ODCase is part of a bifunctional enzyme, UMP synthase, which also contains orotate phosphoribosyltransferase activity. This fusion allows for channeling of the intermediate orotate to OMP, enhancing metabolic efficiency. The bifunctional nature has implications for drug design, as inhibitors must target the ODCase domain without affecting the transferase domain.
Key Genes Involved in GO:0004590 orotidine-5'-phosphate decarboxylase activity
The following genes and proteins are directly involved in orotidine-5'-phosphate decarboxylase activity or its regulation across model organisms and humans.
| Gene | Major Role | Research Relevance |
|---|---|---|
| URA3 (Saccharomyces cerevisiae) | Encodes ODCase; essential for pyrimidine biosynthesis | Classic model for studying enzyme mechanism and as a selectable marker. |
| pyrF (Escherichia coli) | Encodes ODCase; required for UMP synthesis | Bacterial model for enzymology and antibiotic target studies. |
| UMPS (Homo sapiens) | Encodes bifunctional UMP synthase with ODCase and OPRTase activities | Target for anticancer drugs; mutations cause orotic aciduria [2, 6]. |
| PfOMPDC (Plasmodium falciparum) | Bifunctional ODCase-OPRTase; essential for parasite pyrimidine synthesis | Potential antimalarial drug target. |
| PYR1 (Arabidopsis thaliana) | ODCase involved in plant pyrimidine biosynthesis | Model for plant metabolism and herbicide development. |
| pyrE (Bacillus subtilis) | ODCase; part of the pyrimidine operon | Model for gene regulation and antibiotic resistance. |
| TK1436 (Thermococcus kodakarensis) | ODCase from hyperthermophile | Model for thermostability and evolution. |
| Methanocaldococcus jannaschii MJ1543 | ODCase homolog | Model for archaeal enzymology. |
| Leishmania donovani ODC | ODCase in protozoan parasite | Target for antiparasitic drugs. |
| Trypanosoma brucei ODC | ODCase in African trypanosome | Target for sleeping sickness therapy. |
| Candida albicans URA3 | ODCase; essential for pyrimidine synthesis | Antifungal target. |
| Cryptococcus neoformans URA3 | ODCase; virulence factor | Antifungal target. |
| Aspergillus fumigatus pyrF | ODCase; required for growth | Antifungal target. |
| Mycobacterium tuberculosis pyrF | ODCase; essential for survival | Antitubercular target. |
| Human UMPS variants | Mutations affecting ODCase activity | Diagnostic markers for orotic aciduria. |
| Yeast URA3 reporter | ODCase as reporter for gene expression | Tool for high-throughput screening. |
| E. coli pyrF knockout | ODCase deletion mutant | Model for auxotrophy and metabolic engineering. |
| Plasmodium falciparum OMPDC | Bifunctional enzyme | Antimalarial drug discovery. |
How Is orotidine-5'-phosphate decarboxylase activity Regulated?
The expression and activity of ODCase are regulated at multiple levels. In yeast, URA3 expression is controlled by pyrimidine availability through a transcriptional feedback mechanism involving the URA3 gene product itself. In humans, UMPS is regulated by the availability of substrates and feedback inhibition by UMP, the end product of the pathway. Additionally, the bifunctional UMP synthase can be regulated by phosphorylation, although the exact kinases remain to be fully elucidated. Post-translational modifications and allosteric regulation may also play roles, but these are less well characterized.
orotidine-5'-phosphate decarboxylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UMPS | Hereditary orotic aciduria | Knockout or point-mutation in human cell lines (e.g., HEK293). |
| UMPS | Cancer (e.g., colorectal, pancreatic) | Overexpression and knockdown in cancer cell lines. |
| PfOMPDC | Malaria | Knockout in Plasmodium falciparum or surrogate yeast models. |
| URA3 | Fungal infections | Knockout in Candida albicans or Aspergillus fumigatus. |
| pyrF | Bacterial infections | Knockout in Escherichia coli or Mycobacterium tuberculosis. |
Hereditary Orotic Aciduria
Deficiency in ODCase activity, often due to mutations in the UMPS gene, leads to hereditary orotic aciduria, a rare autosomal recessive disorder characterized by excessive excretion of orotic acid, megaloblastic anemia, and growth retardation. This condition highlights the critical role of GO:0004590 in human metabolism.
Cancer
ODCase is overexpressed in some cancers, and inhibitors of ODCase have shown anticancer activity in preclinical models. Targeting ODCase can disrupt pyrimidine synthesis, leading to cell cycle arrest and apoptosis in cancer cells. Structure-activity relationship studies of ODCase inhibitors have identified potent compounds with potential for further development.
Infectious Diseases
ODCase is essential for the survival of pathogens such as Plasmodium falciparum, the causative agent of malaria. The bifunctional ODCase-OPRTase enzyme in Plasmodium is a promising target for antimalarial drugs. Similarly, ODCase from other parasites and fungi represents a potential target for antimicrobial therapy.
Metabolic Disorders
Disruption of pyrimidine metabolism due to ODCase dysfunction can lead to a range of metabolic abnormalities, including orotic aciduria and related conditions. Understanding the regulation of GO:0004590 is crucial for developing therapies for these disorders.
From orotidine-5'-phosphate decarboxylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of ODCase loss on cell viability? | CRISPR knockout of UMPS in human cell lines. |
| How do point mutations in UMPS affect enzyme activity? | Point-mutation knock-in of specific UMPS variants. |
| Can ODCase be tagged for localization studies? | Knock-in of fluorescent tags (e.g., GFP) at the endogenous UMPS locus. |
| What is the effect of ODCase overexpression on drug resistance? | Overexpression of UMPS in cancer cell lines. |
| Which genes interact with ODCase in pyrimidine metabolism? | CRISPR library screening in yeast or human cells. |
| How does ODCase inhibition affect parasite growth? | Knockout or knockdown of PfOMPDC in Plasmodium falciparum. |
How to Study the orotidine-5'-phosphate decarboxylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay | ODCase catalytic activity | Kinetic characterization and inhibitor screening. |
| X-ray crystallography | Three-dimensional structure | Active site mapping and drug design. |
| CRISPR knockout | Gene function and cell viability | Target validation in cancer cells. |
| CRISPR knock-in | Tagged protein localization | Live-cell imaging of ODCase. |
| Metabolomics | Nucleotide pool levels | Pathway flux analysis. |
| RNA-seq | Transcriptional changes | Response to ODCase inhibition. |
| Proteomics | Protein expression and interactions | Identifying ODCase binding partners. |
| High-throughput screening | Inhibitor efficacy | Drug discovery. |
Enzymatic Assays
Direct measurement of ODCase activity using spectrophotometric or HPLC-based assays that monitor the conversion of OMP to UMP. These assays are essential for determining kinetic parameters and inhibitor efficacy.
Structural Biology
X-ray crystallography and NMR spectroscopy to determine the three-dimensional structure of ODCase and its complexes with substrates and inhibitors. These methods reveal the active site architecture and catalytic mechanism.
CRISPR-Based Functional Genomics
CRISPR knockout, knock-in, and point-mutation models to study the role of ODCase in cellular metabolism and disease. Library screening can identify synthetic lethal interactions and resistance mechanisms.
Metabolomics and Flux Analysis
Mass spectrometry-based metabolomics to quantify pyrimidine nucleotides and intermediates, providing insights into pathway flux and regulation.
How CRISPR Can Be Used to Study GO:0004590 orotidine-5'-phosphate decarboxylase activity
Knockout
CRISPR knockout of UMPS or orthologous genes (e.g., URA3, pyrF) creates cell models to study the consequences of ODCase loss, including auxotrophy for uridine and effects on cell proliferation [2, 8]. These models are valuable for validating ODCase as a drug target.
Point Mutation
Introducing specific point mutations identified in patients with orotic aciduria or in cancer allows researchers to dissect the functional impact of these variants on ODCase activity and stability. Point-mutation knock-in models can reveal structure-function relationships.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous UMPS locus enables real-time tracking of ODCase expression and localization in living cells. This approach preserves native regulation and provides insights into spatiotemporal dynamics.
Overexpression
Overexpression of wild-type or mutant UMPS in cell lines can model drug resistance and identify downstream effects of increased ODCase activity. Overexpression models are also useful for biochemical purification and structural studies.
How EDITGENE Supports orotidine-5'-phosphate decarboxylase activity Research
Researchers studying orotidine-5'-phosphate decarboxylase activity-related genes often need to determine whether a candidate gene is causally involved in pyrimidine metabolism, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for orotidine-5'-phosphate decarboxylase activity research.
Frequently Asked Questions About orotidine-5'-phosphate decarboxylase activity
What is orotidine-5'-phosphate decarboxylase activity?
It is the enzyme activity that catalyzes the conversion of orotidine 5'-phosphate to uridine 5'-monophosphate and carbon dioxide, the final step in pyrimidine biosynthesis.
What genes are involved in orotidine-5'-phosphate decarboxylase activity?
Key genes include UMPS in humans, URA3 in yeast, and pyrF in bacteria, all encoding ODCase or bifunctional enzymes with ODCase activity [1, 6, 8].
What is the function of GO:0004590?
GO:0004590 represents the molecular function of ODCase, which is essential for producing UMP, a precursor for RNA and DNA synthesis.
Why is ODCase considered a proficient enzyme?
ODCase accelerates the decarboxylation of OMP by a factor of approximately 10^17, making it one of the most efficient enzymes known.
Does ODCase require metal ions for activity?
No, yeast ODCase retains full activity in the absence of metals, indicating that metals are not required for catalysis.
What diseases are associated with ODCase deficiency?
Deficiency in ODCase activity can cause hereditary orotic aciduria, a rare metabolic disorder.
How is ODCase targeted in cancer therapy?
Inhibitors of ODCase, such as transition-state analogs, have shown anticancer activity by disrupting pyrimidine synthesis.
What model organisms are used to study ODCase?
Common models include Saccharomyces cerevisiae (URA3), Escherichia coli (pyrF), and Plasmodium falciparum (bifunctional ODCase) [1, 6, 8].
What is the bifunctional UMP synthase?
In humans and some parasites, ODCase is fused with orotate phosphoribosyltransferase to form a bifunctional enzyme that channels substrates efficiently.
How can CRISPR be used to study ODCase?
CRISPR knockout, knock-in, and point-mutation models allow researchers to dissect the role of ODCase in metabolism, disease, and drug response [2, 3].
Conclusion
Orotidine-5'-phosphate decarboxylase activity (GO:0004590) is a cornerstone of pyrimidine metabolism and a remarkable example of enzyme efficiency. Its study spans basic enzymology, structural biology, and translational medicine, with implications for cancer, infectious diseases, and inherited metabolic disorders. By leveraging CRISPR-based models and advanced bioinformatics, researchers can continue to uncover the mechanistic details and therapeutic potential of this essential activity.
References
- 1. Miller BG et al.. 1999. Activity of yeast orotidine-5'-phosphate decarboxylase in the absence of metals.. J Biol Chem 274(34):23841-3 PMID: 10446147
- 2. Bello AM et al.. 2009. Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.. J Med Chem 52(6):1648-58 PMID: 19260677
- 3. Cristobal JR et al.. 2021. Protein-Ribofuranosyl Interactions Activate Orotidine 5'-Monophosphate Decarboxylase for Catalysis.. Biochemistry 60(45):3362-3373 PMID: 34726391
- 4. Richard JP et al.. 2018. Orotidine 5'-Monophosphate Decarboxylase: Probing the Limits of the Possible for Enzyme Catalysis.. Acc Chem Res 51(4):960-969 PMID: 29595949
- 5. Miller BG et al.. 2000. Contribution of enzyme-phosphoribosyl contacts to catalysis by orotidine 5'-phosphate decarboxylase.. Biochemistry 39(28):8113-8 PMID: 10889016
- 6. Paojinda P et al.. 2018. Bifunctional activity of fused Plasmodium falciparum orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase.. Parasitol Int 67(1):79-84 PMID: 28389349
- 7. Radzicka A et al.. 1995. A proficient enzyme.. Science 267(5194):90-3 PMID: 7809611
- 8. Donovan WP et al.. 1983. Purification and characterization of orotidine-5'-phosphate decarboxylase from Escherichia coli K-12.. J Bacteriol 156(2):620-4 PMID: 6355062
